What East West Pharma does

East West Pharma India Pvt. Ltd. is an Indian pharmaceutical formulations company headquartered in Salem, Tamil Nadu, with a WHO-GMP and ISO 9001:2015 accredited manufacturing facility in Roorkee producing tablets, capsules, topical formulations, liquid orals, dry syrups, and sterile injectables. The company's R&D team has developed a portfolio of over 900 products across 14 therapeutic segments, including clinical dermatology, aesthetic dermatology, cardiology, diabetology, neuro-psychiatry, gynaecology, orthopedics, urology and nephrology, gastroenterology, pulmonology, paediatrics, antibiotics, antihistamines, and nutraceutical supplements. It is known for brands such as MINSCALP, KETAFUNG, BETALOL, TOFAMOD, and ENDOBLIS, and operates dedicated therapy-area divisions including CYNOR (neuropsychiatry, orthopedics, urology, nephrology) and a dermatology-focused aesthetic and trichology line.

The company distributes through 12+ depots and C&Fs and a network of over 500 distributors across India, supported by a frontline field sales force and a rural outreach initiative reaching villages and micro-interiors. It generates revenue primarily through one-time sales of pharmaceutical products via field sales and wholesale distribution, with no publicly disclosed pricing model. Marketing is executed through active participation in national and regional medical conferences (DERMACON, KNACON, IPSOCON, NATPUCON, FOGSI, RSSDI, etc.), CME booklets, the GLOW and EVOLVE webinar series, and a South Zone newsletter distributed to roughly 750 doctors. As of IQVIA MAT March 2023, the South Zone turnover was ₹190 crores growing at 65%, and the company ranked 87th in the Indian Pharma Industry per IQVIA December 2023.

Recent strategic moves include a 2024 launch of export activities into Maldives, Bhutan, and Ecuador, the 2024 expansion of commercial operations from South India into the North, East, and West zones, and a September 2025 MoU with Thiruvalluvar University under the East West NextGen initiative to train pharmaceutical sales and marketing professionals. Leadership is anchored by Joint Managing Director Mr. Sabarish Mohankumar. The company operates as a privately held entity with no disclosed venture capital, private equity, or institutional investor involvement.

Name

East West Pharma

Legal name

East West Pharma India Pvt. Ltd.

Website

https://eastwestpharma.in

Company type

Private

Operating status

Operating

Headcount range

501–1,000 employees

Short description

East West Pharma is an Indian pharmaceutical formulations company headquartered in Salem, Tamil Nadu, manufacturing 900+ products across 14 therapeutic segments including dermatology, cardiology, diabetology, neuro-psychiatry, and gynaecology, distributed via 500+ distributors and 12+ depots across India.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)

akta.pro secondary industries

Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE), Gastroenterology & Hepatology Pharmaceuticals (HLAIAAAI), Ophthalmology Pharmaceuticals (HLAIAAAL)

Keywords

• Pharmaceutical manufacturing
• Dermatology formulations
• Generic medicines
• Nutraceutical supplements
• Topical formulations

Headquarters

HQ city

Salem

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Revenue generated from manufacturing and selling pharmaceutical products across multiple therapeutic segments including dermatology, cardiology, diabetology, neuro-psychiatry, gynaecology, orthopedics, and others. Products are distributed through depots, C&Fs, and 500+ distributors across India.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

Core offering

East West Pharma manufactures and sells 900+ pharmaceutical formulations across 14 therapeutic segments including Clinical Dermatology, Aesthetic Dermatology, Cardiology, Diabetology, Neuro-Psychiatry, Gynaecology, Orthopedics, Gastroenterology, Urology & Nephrology, Pulmonology, Paediatrics, Antihistamines, Antibiotics, and Nutraceutical Supplements. Products are produced at a WHO-GMP and ISO 9001:2015 accredited manufacturing facility in Roorkee and distributed through 12+ depots and 500+ distributors across India via a frontline field sales force.

Product overview

East West Pharma is an Indian pharmaceutical company offering a diverse portfolio of over 900 products across 14 therapeutic segments. The company's product portfolio spans Clinical Dermatology (TOFAMOD, TOFAMOD-AD, Dersol, Pinoin, Ketafung, Cligel, Clomic, Loprolif, Dermotex, Betadip, Finabald), Aesthetic Dermatology (GLUFAIR, Dershine, DEINOBLOC UV, FolGROOM Pro Advanced, C-Bliz, PL Gel 2.5), Cardiology (Roliptin EZ, Cilnipres, Betalol), Diabetology (METHICO PLUS, ESGEDAP, GRIDE MS, Diapod-FC), Neuro-Psychiatry (Arize, Olpin, Ridon, Pregarol, Levinz, Sebenz, Vitrace Nervz), Gynaecology (Endoblis, PROVAGEST, Dydrotreat), Gastroenterology (SPORIL-IBS), Urology & Nephrology (Orempa, Siloplas), Antibiotics (Cebox, Macroclar, Decef), and Nutraceutical Supplements (Vitrace, Vitrace Gold, Ergo Flex, Octoros, Virozinc). The company operates with cGLP and WHO-GMP compliant manufacturing facilities and focuses on differentiated products across these therapeutic areas.

Differentiator

Problem solved

Functional benefit

Products and services

• MINSCALP Hair regrowth product primarily for androgenetic alopecia. Available in various formulations including gel (2%, 5%, 10%), lotion, and tablets (Minscalp Forte).
• GLUFAIR Skin brightening and lightening kit containing L-Glutathione, Grape Seed Extract, Alpha Lipoic Acid, and Vitamin C. Also available as creamy face wash.
• TOFAMOD Tofacitinib Citrate 5mg tablet for oral immunomodulation in dermatological conditions.
• TOFAMOD-AD Tofacitinib 2% ointment for topical immunomodulation in dermatological conditions.
• Dersol Salicylic acid ointment available in various concentrations (3%, 6%, 12%, 18%, 24%, 30%, 40%) for keratolytic treatment.
• Roliptin EZ Cardiology medication showcased at conferences for cardiovascular care.
• METHICO PLUS Diabetology product for diabetic peripheral neuropathy (DPN) management.
• Endoblis Dienogest 2mg formulation for long-term medical management of endometriosis in women.
• OPTI-FN Ophthalmology product for eye care segment.
• PL Gel 2.5 Lidocaine and Prilocaine anesthetic gel (2.5% each) for aesthetic dermatology procedures.
• SPORIL-IBS Product for Irritable Bowel Syndrome management in gastroenterology segment.
• PROVAGEST Gynaecology product showcased at TNFOG conference, generating interest among KOLs.
• Pinoin Isotretinoin capsules (5mg, 10mg, 20mg) and topical tretinoin cream (0.025%, 0.05%) for anti-acne treatment.
• Ketafung Ketoconazole-based antifungal product available as tablets, cream, lotion, and soap for fungal infections.
• Cligel Clindamycin phosphate gel (1%) with variations including Cligel-N (with nicotinamide), Cligel-T (with tretinoin), and Cligel-A (with adapalene) for anti-acne treatment.
• Clomic Clobetasol propionate topical steroid available as cream, ointment, and lotion in various strengths and combinations.
• Loprolif Tacrolimus ointment (0.03%, 0.1%) and capsules (0.5mg, 1mg, 2mg, 5mg) for oral immunomodulation.
• Dermotex Methotrexate tablets (2.5mg, 5mg, 7.5mg, 10mg, 15mg) and gel for oral immunomodulation.
• Betadip Beclomethasone dipropionate topical steroid cream with variations including Betadip-Z with zinc sulphate.
• Finabald Finasteride tablets (0.5mg, 1mg, 2.5mg, 5mg) for male pattern baldness treatment.
• Cebox Cefuroxime axetil antibiotic tablets (125mg, 250mg, 500mg) for bacterial infections.
• Macroclar Clarithromycin antibiotic tablets (250mg, 500mg) for bacterial infections.
• Decef Sterile cefoperazone sodium with sulbactam sodium injection for serious bacterial infections.
• Vitrace Multivitamin and mineral supplement tablet containing thiamine, riboflavine, pyridoxine, niacinamide, folic acid, vitamin C, vitamin D3, and trace minerals.
• Vitrace Gold Advanced multivitamin supplement with silymarin, L-lysine, N-acetyl cysteine, and essential vitamins and minerals.
• Ergo Flex L-Glutathione and curcumin-based supplement with antioxidants including vitamin C, E, beta carotene, and resveratrol.
• Octoros Antioxidant supplement containing oxyresveratrol, astaxanthin, tetrahydrocurcuminoids, coenzyme Q10, and vitamins.
• Virozinc Vitamin C (500mg), Vitamin D (2000 I.U.), and Zinc (50mg) supplement for immune support.
• Dershine Aloe vera-based emollient soap and cream with glycerin and vitamin E for skin moisturization.
• DEINOBLOC UV Advanced sunscreen gel with zinc oxide, titanium dioxide, and UV filters for broad-spectrum sun protection.
• UV BROAD Tinted Sunscreen Tinted sunscreen product showcased at CUTICON Kerala 2024 for sun protection with aesthetic dermatology applications.
• FolGROOM Pro Advanced Hair serum with procapil (apigenin, oleanolic acid, biotinoyl tripeptide), moringa, and fenugreek for trichology applications.
• C-Bliz Vitamin C 20% serum with hyaluronic acid, ferulic acid, and baobab oil for face rejuvenation.
• Arize Aripiprazole product for psychiatric conditions.
• Olpin Olanzapine product for psychiatric conditions.
• Ridon Risperidone product for psychiatric conditions.
• Pregarol Pregabalin product for neurological conditions, highlighted at KNACON 2023.
• Levinz Levetiracetam product for neurological conditions, highlighted at KNACON 2023.
• Sebenz Clobazam product for neurological conditions, highlighted at KNACON 2023.
• Vitrace Nervz Nerve nutrition supplement highlighted at KNACON 2023.
• Cilnipres Cardiovascular product showcased at nephrology conferences for cardio-renal-metabolic space.
• Betalol Nebivolol product, among top brands in pharma industry in Tamil Nadu according to IQVIA report.
• ESGEDAP Diabetes management product featured at KAPICON 2025 and RSSDI conferences.
• GRIDE MS Diabetes management product showcased at KAPICON 2025.
• Diapod-FC Foot cream for prophylactic podiatric care in diabetes management.
• Orempa Nephrology product showcased at NATPUCON 2025.
• Siloplas Nephrology product showcased at NATPUCON 2025.
• Dydrotreat Gynaecology product generating interest at TNFOG conference.
• Minscalp Plus First in India formulation with saw palmetto, minoxidil, and azelaic acid for acne and hair loss management.
• Anti-Acne Portfolio (Cleansing & Conditioning Shampoo) Cleansing and conditioning shampoo for acne and hair loss management.

Quantifiable outcome

• 65% growth rate in South Zone (IQVIA MAT March 2023)
• +3 more outcomes

Named customers6 records

Segments8 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Thiruvalluvar UniversitycoreStrategic or Co-development Partner · 1 September 2025East West Pharma signed MoU with Thiruvalluvar University, Serkkadu, Vellore, to offer a Certificate Course in Pharmaceutical Sales & Marketing. The partnership includes a six-month certificate course in pharmaceutical marketing & sales and a one-year Diploma course in Advanced pharma marketing & product sales management. This initiative called 'East West NextGen' aims to foster skilled professionals and bridge the gap between academic preparation and professional requirements in the pharmaceutical sector.

Scale indicators8 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• JB Chemicals & Pharmaceuticals: Mid-cap Indian pharma with branded formulations across multiple therapies, comparable in scale and in its reliance on specialist-physician detailing for chronic segments.
• Alkem Laboratories: Indian branded-generic player with broad therapeutic coverage, similar multi-therapy segmentation approach, and large domestic field force in chronic categories.
• Glenmark Pharmaceuticals: Mid-to-large Indian pharma with overlapping therapy mix (dermatology, cardiology, diabetology, respiratory) and significant branded-generic domestic franchise.
• Ajanta Pharma: Strong Indian derma player with branded specialty portfolio and pan-India field force; highly comparable in dermatology and aesthetic dermatology positioning.
• Eris Lifesciences: Indian mid-cap chronic-care pharma with strong super-specialty physician relationships in cardiology, diabetology, and derma — directly comparable therapy mix and field-sales GTM.
• Intas Pharmaceuticals: Indian private pharma with branded generics across multiple therapeutic areas including derma, neuro-psychiatry and cardiology, with comparable specialty-physician detailing focus.
• Mankind Pharma: Indian mid-cap pharma with a similarly broad multi-therapy chronic/acute portfolio and a heavy field-sales model targeting specialists — closest comparable in scale and GTM motion.

Broad incumbents

• Cipla: One of India's largest pharma incumbents with broad therapy coverage including derma, respiratory and cardiology — sets the competitive ceiling East West is operating beneath.
• Torrent Pharmaceuticals: Larger Indian pharma with strong chronic-care portfolio (cardiology, diabetology, neuro-psychiatry); not niche derma like East West, but overlapping therapy footprint makes it a relevant comparable.

Emerging players

• Vasu Healthcare: Niche Indian derma and trichology-focused player (MINOXI, Bhringaraj); overlaps in trichology and clinical-aesthetic dermatology, useful as a focused derma peer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/pharmaew
• Facebookfacebook.com/eastwestpharma.wp

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about East West Pharma